By InvestAdvocate

Lagos (INVESTADVOCATE)-Pharmaceutical firm, Neimeth International Pharmaceuticals Plc has appointed Ebere Igboko Ekpunobi as substantive managing director/chief executive officer effective March 1, 2016, the drugmaker said Tuesday in an issuer’s announcement with the Nigerian Stock Exchange (NSE).

Ekpunobi is already in acting capacity from November 23, 2015 following the  retirement of  Emmanuel Ekunno as CEO of the company effective February 28, 2016.

“Ekunno has however, embarked on his terminal leave,” Neimeth affirmed.